http://orcid.org/0000-0001-6849-421X
About the Authors
- Clément Guillot
-
Roles Formal analysis, Investigation, Methodology, Writing – review & editing
Affiliation Centre de Recherche en Cancérologie de Lyon INSERM U1052, CNRS UMR5286, Université de Lyon, Lyon, France
- Nora Martel
-
Roles Formal analysis, Investigation, Methodology, Writing – review & editing
Affiliation Centre de Recherche en Cancérologie de Lyon INSERM U1052, CNRS UMR5286, Université de Lyon, Lyon, France
- Françoise Berby
-
Roles Investigation
Affiliation Centre de Recherche en Cancérologie de Lyon INSERM U1052, CNRS UMR5286, Université de Lyon, Lyon, France
- Isabelle Bordes
-
Roles Investigation
Affiliation Centre de Recherche en Cancérologie de Lyon INSERM U1052, CNRS UMR5286, Université de Lyon, Lyon, France
- Olivier Hantz
-
Roles Methodology, Writing – review & editing
Affiliation Centre de Recherche en Cancérologie de Lyon INSERM U1052, CNRS UMR5286, Université de Lyon, Lyon, France
- Matthieu Blanchet
-
Roles Methodology, Writing – review & editing
Affiliation Replicor Inc. Montréal, Canada
- Camille Sureau
-
Roles Methodology, Writing – review & editing
Affiliation Molecular Virology Laboratory, Institut National de la Transfusion Sanguine (INTS), CNRS INSERM U1134, Paris, France
- Andrew Vaillant
-
Roles Conceptualization, Methodology, Project administration, Writing – review & editing
* E-mail: isabelle.chemin@inserm.fr (IC); availlant@replicor.com (AV)
Affiliation Replicor Inc. Montréal, Canada
- Isabelle Chemin
-
Roles Conceptualization, Methodology, Project administration, Writing – review & editing
* E-mail: isabelle.chemin@inserm.fr (IC); availlant@replicor.com (AV)
Affiliation Centre de Recherche en Cancérologie de Lyon INSERM U1052, CNRS UMR5286, Université de Lyon, Lyon, France
Competing Interests
Matthieu Blanchet and Andrew Vaillant are employees of Replicor Inc. Andrew Vaillant is a shareholder in Replicor Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.